Taiwan(3) Hepatitis B virus(3) lamivudine(2) SARS‐CoV‐2(2) infection control(2) entecavir(2) Novel coronavirus(2) COVID‐19(2) Hepatocellular carcinoma(2) CRP(1) Single nucleotide polymorphism(1) Human immunodeficiency virus(1) FIB-4(1) host-dominating flare(1) fine-needle aspiration(1) Treg(1) Synergy index(1) Chronic Hepatitis B(1) 2019 novel coronavirus (SARS-CoV-2)(1) telbivudine(1) age-adjusted(1) stopping rule(1) outcome(1) ESR(1) Hepatitis B related hepatocellular carcinoma(1) Injecting drug users(1) Infectious diseases(1) CAGR(1) HBsAg loss(1) Disease burden(1)